Author Guidelines

Table of Contents

1.           Overview

2.           Scope

3.           Manuscript categories and submission requirements

4.           Manuscript preparation

5.           Editorial policies and ethical considerations

6.           Publication process after acceptance

7.           Post publication

8.           Contact details 

1. OVERVIEW

Medical Science & Innovation(MSI) is a leading international journal focused on the global exchange of knowledge in medical science, as well as advancing research and practice across medical disciplines. The journal provides a forum for articles reporting on original research, review articles and case studies focused on medical science, clinical practice and education from around the world.

2. SCOPE

MSI is a multidisciplinary journal dedicated to advancing the frontiers of medicine through the integration of the One Health approach. One Health recognizes the interdependence of human, animal, and environmental health and seeks to revolutionize medical science by addressing complex global health challenges at their intersection. As a multidisciplinary journal, MSI is covering the wide range of research in medicine, including basic medicine, clinical medicine, social medicine, veterinary medicine, bioscience, and medical engineering

3. MANUSCRIPT CATEGORIES AND SUBMISSION REQUIREMENTS

Categories

Authors from all medical disciplines are invited to submit manuscripts and benefit from our strong reputation, international readership, and rapid publication times. The types of articles published in MSI include:

• Original research, including basic science, translational, and clinical research.
• Research methodology
• Systematic reviews of research evidence (qualitative, quantitative, mixed methods); meta-analyses, meta-syntheses following PRISMA guidelines (narrative or traditional literature reviews are not accepted for publication)
• Scoping reviews
• Education articles
• Scholarly papers presenting in-depth analysis and discussion of philosophical, theoretical, conceptual, professional practice, policy issues or innovations in medicine
• Brief reports of original studies or evaluations
• Commentaries and responses to commentaries on previous articles published in MSI (include all details of the published article)
• Manuscripts concerning the development and testing of the psychometric properties of instruments across cultures will not be considered for publication unless the authors can show that their research adds significantly to the literature in the field, the findings show something novel, and it is of interest to international readers.
• medical engineering

Priority is given to research that:

• adds to current knowledge
• shows depth, rigor, originality, and a high standard of presentation
• is of high scientific quality, with methods and analysis appropriate to the research question(s)
• is relevant to an international readership
• follows the applicable reporting guidelines
• is likely to contribute to improvements in clinical practice, medical care, education or further research

Keywords

Basic research, translational research, clinical research, collaborative research, integrated professional practice, interdisciplinary practice, primary health care, health promotion, non-communicable diseases, technological innovations, multicultural, physical therapy, occupational therapy and social work.

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database such as https://www.umin.ac.jp/ctr/index-j.html and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number in the title page. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

4. MANUSCRIPT PREPARATION

Cover Letter

The cover letter should include:

1. Statement to confirm that the manuscript has not been published or submitted for publication elsewhere.
2. Author Contributions: Please write in the following format;
      Study design: John W. Smith, Emily White
      Data collection: Peter Jones, Hana Kim
      Data analysis: Sachiko Tanaka, David S. Williams
      Manuscript writing: Mary J. E. Thompson, Jenny Nguyen, Peter Brown
3. Statement that all authors have approved the content before submission, or resubmission.
4. Conflict of interest statement. Authors are required to disclose any possible conflict of interest when submitting a paper. If the author does not have any conflict of interest the following statement should be included: “No conflict of interest has been declared by the author(s).”
5. Funding statement. Specify sources of funding (institutional, private and corporate financial support) for the work reported in their paper.
6. Statement that the research conforms to the provisions of the Declaration of Helsinki (as revised in Brazil 2013). All participants gave informed consent for the research, and that their anonymity was preserved.
7. Statement that the protocol for the research project was approved by a suitably constituted research ethics committee of the institution within which the work was undertaken and include the title of the committee(s) and research approval number in the cover letter as well as the manuscript.
8. The editors encourage authors to provide the names of at least two potential　reviewers.　
9. Fill in your autograph at the end.

Parts of Manuscripts

Documents required for submission. These should be submitted as separate files.

Title page

The title page should contain:

1. Manuscript category;
2. Title
3. A short running title of less than 50 characters;
4. All authors' full names (please put the first letter in CAPITAL) and qualifications;
5. Corresponding author: The full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent;
6. Author's institutional affiliations at which the work was carried out;
7. Word counts (this should not include abstract, keywords, key points, tables, figures and references);
8. Registration of clinical trial and registration identification number

Main text file

The length of papers should adhere to the guidelines outlined for each manuscript type. As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors.
The main text file should be presented in the following order: (i) abstract and key words (ii) main text, (iii) references.
The text should be double-spaced.
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Authors should use subheadings to divide the sections of their manuscript as outlined for each article type.

Acknowledgments can be added at the end of main text.
Note that word counts should not include tables and figures.

Conflict of Interest At the time of submission, financial or personal involvements that pose a potential conflict of interest for authors should be clearly declared in front of References under a separate heading entitled “Conflict of Interest.” If no conflicts exist, please use the standard phrase, “The authors declare no conflict of interest.”　 The phrase should be marked before the reference

(i) Abstract, key words and key points

All articles must have an abstract that states in 200 words or less the purpose, basic procedures, main findings, principal conclusions of the study, and implications for practice. The abstract should not contain abbreviations, p values, confidence intervals or other statistical parameters.
No more than five key words (for the purposes of indexing) should be supplied below the abstract.

(ii) Main text

Original research and education articles:

Original Articles should not exceed 5,000 words. The main text should be structured as follows: Introduction (putting the paper in context - policy, practice or research); Background (literature); Methods (design, data collection and analysis); Results; Discussion; Conclusion; Relevance for clinical practice.

Systematic Reviews:

Medical Science & Innovation accepts systematic reviews using any robust methodology for reviews of the effects of interventions, qualitative reviews, prevalence and incidence, economics, diagnostic test accuracy, prognosis/risk, psychometric properties of measurement instruments, and mixed-methods systematic reviews.

(iii) References

References should be indicated by numerical superscripts in the text and sequentially stated in full at the end of the main text. The numbering of the references should be in order of citation in the text, and each reference should be given a separate number. Since tables and figures will be inserted in the text where first cited, references in these sections should be numbered accordingly. Only papers that either have been published or are in press may be cited in the reference list.

　The following nonprimary sources are not valid for listing: “unpublished data,” “personal communication,” “manuscript in preparation,” “manuscript submitted,” and pamphlets. These sources may be cited parenthetically in the text. An article available only in Japanese should be so noted after its title. For correct abbreviations of journal titles, the authors should refer to the January issue of Index Medicus of the current year. Some examples of forms of references are as follows:

　　1. Li FJ, Tsuyama N, Ishikawa H, Obata M, Abroun S, Liu S, Otsuyama K, Zheng X, Ma Z, Maki Y, Kawano MM. A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma. Blood. 2005 Apr 15;105(8):3295-302. doi: 10.1182/blood-2004-10-4083. Epub 2004 Dec 30.

　　2. Kretschmer PJ, Cohen SN. Selected translation of DNA segments containing antibiotic resistance genes. In Bukhari AI, Shapiro JA, Adhya SL (eds.), DNA Insertion Elements, Plasmids and Episomes, Cold Spring harbor Laboratory. Cold Spring Harbor. 1977 pp.549-554.

　　3. Hall RH. The Modified Nucleosides in Nucleic Acids. Columbia University Press, New York. 1971.p206.

　　4. Ueda K. In vitro replication of phage φX174DNA (in Japanese). Seikagaku. 1978 50(4): 241-265.

　　5. Masuda M, Yamaoka H, Isigulo, K, Matsumoto T, Takahashi M. The periodic loss of metabolically unstable DNA from newly replicated DNA of mouse L cells. Bull. Yamaguchi Med. Sch., in press.1980 Dec 27(3-4):117-124.

Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Statistical measures such as SD or SEM should be identified in the headings.

Statistics
The advice of a statistician should always be sought for quantitative studies, and this person should be acknowledged in the acknowledgement section if the paper is accepted for publication. Where other than simple descriptive statistics are used, a statistician should be included as one of the authors.

Format
The main text file should be prepared using Microsoft Word, doubled-spaced.
Set the default language to English in Word Options.
Set the file size to A4.
Set the margins to A4 standard size: Top 30.1, Bottom 30.0mm, Right, Left 30.0mm

 (iv) Supporting Information

Supporting information is hosted online separately to the article. This should be used for information that is not essential to the article but that provides greater depth and background. It may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Please note that the provision of supporting information is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Review and Acceptance

Except where otherwise stated, manuscripts are peer-reviewed by two reviewers, and Editor and Editor in Chief. The final decision about suitability for publication rests with the Editorial Team (Editors and Editor in Chief).

 
An appeal against a decision regarding the rejection of a manuscript should be filed within 28 days of notification of the decision. Appeals will only be considered when the decision to reject a manuscript was based on a serious scientific misunderstanding of a core aspect of the manuscript or if you perceive there is a conflict of interest. 


Principles for Publication of Research Involving Human Participants

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee. The full name of the ethics committee and approval number should be included. It should also state clearly in the text that all participants gave their informed consent prior to their inclusion in the study and that anonymity is preserved. Details that might disclose the identity of study participants should be omitted.

Authorship and Acknowledgements

All contributing authors must have significantly contributed to the research and writing of the manuscript, and approved the content before submission, or resubmission.

Disclosure Statement

The journal requires that all authors disclose any potential sources of conflict of interest.


Plagiarism Detection

The journal employs a plagiarism detection system. This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

6. PUBLICATION PROCESS AFTER ACCEPTANCE